ArticleOncotarget2017
Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer.
Radhashree Maitra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleOncotarget2017
Radhashree Maitra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.